Naples Global Advisors’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $651K | Sell |
6,289
-20
| -0.3% | -$1.78K | 0.04% | 301 |
|
|
2026
Q1 | $453K | Sell |
6,309
-814
| -11% | -$62.7K | 0.03% | 341 |
|
|
2025
Q4 | $565K | Sell |
7,123
-1,123
| -14% | -$88.5K | 0.04% | 306 |
|
|
2025
Q3 | $622K | Buy |
8,246
+221
| +3% | +$15.1K | 0.05% | 289 |
|
|
2025
Q2 | $554K | Sell |
8,025
-694
| -8% | -$45.5K | 0.05% | 289 |
|
|
2025
Q1 | $591K | Sell |
8,719
-4,173
| -32% | -$250K | 0.06% | 273 |
|
|
2024
Q4 | $579K | Sell |
12,892
-7,866
| -38% | -$441K | 0.05% | 274 |
|
|
2024
Q3 | $1.31M | Sell |
20,758
-2,123
| -9% | -$124K | 0.12% | 189 |
|
|
2024
Q2 | $1.35M | Sell |
22,881
-4,493
| -16% | -$281K | 0.14% | 180 |
|
|
2024
Q1 | $2.18M | Sell |
27,374
-10,675
| -28% | -$815K | 0.22% | 128 |
|
|
2023
Q4 | $3M | Sell |
38,049
-684
| -2% | -$48.7K | 0.33% | 89 |
|
|
2023
Q3 | $2.7M | Buy |
38,733
+3,370
| +10% | +$239K | 0.33% | 91 |
|
|
2023
Q2 | $2.44M | Buy |
35,363
+2,653
| +8% | +$189K | 0.29% | 101 |
|
|
2023
Q1 | $2.43M | Buy |
32,710
+2,227
| +7% | +$187K | 0.3% | 98 |
|
|
2022
Q4 | $2.84M | Sell |
30,483
-594
| -2% | -$57.3K | 0.36% | 83 |
|
|
2022
Q3 | $2.96M | Buy |
31,077
+977
| +3% | +$96.7K | 0.41% | 75 |
|
|
2022
Q2 | $2.79M | Buy |
30,100
+278
| +0.9% | +$27.1K | 0.36% | 88 |
|
|
2022
Q1 | $3.02M | Buy |
29,822
+980
| +3% | +$103K | 0.35% | 85 |
|
|
2021
Q4 | $2.98M | Buy |
28,842
+317
| +1% | +$29.3K | 0.34% | 88 |
|
|
2021
Q3 | $2.42M | Buy |
28,525
+832
| +3% | +$69.7K | 0.32% | 94 |
|
|
2021
Q2 | $2.31M | Buy |
27,693
+3,096
| +13% | +$254K | 0.32% | 95 |
|
|
2021
Q1 | $1.85M | Buy |
24,597
+912
| +4% | +$66.4K | 0.28% | 109 |
|
|
2020
Q4 | $1.62M | Buy |
23,685
+158
| +0.7% | +$10.3K | 0.27% | 112 |
|
|
2020
Q3 | $1.37M | Buy |
23,527
+6,285
| +36% | +$391K | 0.27% | 116 |
|
|
2020
Q2 | $1.12M | Buy |
17,242
+685
| +4% | +$43.1K | 0.24% | 123 |
|
|
2020
Q1 | $982K | Buy |
16,557
+6,568
| +66% | +$438K | 0.26% | 125 |
|
|
2019
Q4 | $742K | Buy |
9,989
+233
| +2% | +$16.4K | 0.16% | 180 |
|
|
2019
Q3 | $615K | Buy |
9,756
+99
| +1% | +$5.87K | 0.14% | 191 |
|
|
2019
Q2 | $526K | Sell |
9,657
-690
| -7% | -$37.2K | 0.13% | 206 |
|
|
2019
Q1 | $558K | Buy |
10,347
+851
| +9% | +$52.5K | 0.14% | 195 |
|
|
2018
Q4 | $622K | Buy |
9,496
+911
| +11% | +$68K | 0.18% | 171 |
|
|
2018
Q3 | $676K | Buy |
8,585
+298
| +4% | +$21.3K | 0.18% | 171 |
|
|
2018
Q2 | $533K | Buy |
8,287
+452
| +6% | +$29.8K | 0.15% | 194 |
|
|
2018
Q1 | $487K | Buy |
7,835
+300
| +4% | +$21.5K | 0.14% | 196 |
|
|
2017
Q4 | $546K | Sell |
7,535
-533
| -7% | -$38.8K | 0.16% | 181 |
|
|
2017
Q3 | $656K | Buy |
8,068
+223
| +3% | +$17.6K | 0.22% | 149 |
|
|
2017
Q2 | $631K | Buy |
7,845
+2,090
| +36% | +$165K | 0.22% | 146 |
|
|
2017
Q1 | $452K | Buy |
+5,755
| New | +$459K | 0.16% | 184 |
|
|
2016
Q4 | – | Sell |
-2,887
| Closed | -$257K | – | 253 |
|
|
2016
Q3 | $257K | Buy |
2,887
+155
| +6% | +$14.6K | 0.1% | 233 |
|
|
2016
Q2 | $262K | Sell |
2,732
-75
| -3% | -$7.47K | 0.11% | 224 |
|
|
2016
Q1 | $291K | Buy |
+2,807
| New | +$273K | 0.12% | 215 |
|
Other funds holding CVS
Naples Global Advisors's CVS Position: Q2 2026 in Review
Naples Global Advisors reduced its CVS Health (CVS) stake by 0.32% in Q2 2026, selling an estimated $1.78K and leaving 6,289 shares worth $651K. The position accounts for 0.04% of the portfolio, ranked #301.
Naples Global Advisors first reported a position in CVS in Q1 2016 and has held it in 41 quarters since. The position peaked at $3.02M in Q1 2022. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Naples Global Advisors held 6,289 shares of CVS Health worth $651K as of Q2 2026.
- Naples Global Advisors sold 20 CVS Health shares in Q2 2026, an estimated $1.78K.
- CVS Health made up 0.04% of Naples Global Advisors's portfolio in Q2 2026, its #301 holding.
- Naples Global Advisors first reported a position in CVS Health in Q1 2016 and has held it in 41 quarters since.
- Naples Global Advisors's CVS Health position peaked at $3.02M in Q1 2022.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Naples Global Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.